IP Library Granted Patent US 10,596,038
Granted Patent B2
US 10,596,038 · App. 15/684,010 · Granted Mar 24, 2020

Corneal denervation for treatment of ocular pain

Inventors: Yair Alster (Tel-Aviv, IL); Hanson S. Gifford (Woodside, CA); Cary J. Reich (Los Gatos, CA); Eugene De Juan, Jr. (San Francisco, CA); John A. Scholl (San Ramon, CA); Jose D. Alejandro (Sunnyvale, CA); Douglas Sutton (Pacifica, CA); Omer Refaeli (Tel-Aviv, IL)
Assignee: JOURNEY1, INC.
A61F9/008A61F9/00804A61B18/02A61F9/009A61F9/0079A61F2009/00872A61F2009/00893A61N1/36021A61N1/36046A61N1/40A61N7/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,596,038
App. No.
15/684,010
Granted
Mar 24, 2020
Kind
B2
Abstract

Methods and apparatus for the treatment of the eye to reduce pain can treat at least an outer region of the tissue so as to denervate nerves extending into the inner region and reduce the pain. For example, the cornea of the eye may comprise an inner region having an epithelial defect, and an outer portion of the cornea can be treated to reduce pain of the epithelial defect. The outer portion of the cornea can be treated to denervate nerves extending from the outer portion to the inner portion. The outer portion can be treated in many ways to denervate the nerve, for example with one or more of heat, cold or a denervating noxious substance such as capsaicin. The denervation of the nerve can be reversible, such that corneal innervation can return following treatment.

Claims (28)

1. A method of treating a cornea of an eye, comprising:

applying an apparatus to an anterior surface of a cornea, wherein the cornea comprises an epithelium, a stroma, an inner portion and an outer portion; and

applying energy from the apparatus to denervate a region of the cornea corresponding to a denervation treatment profile,

wherein denervating comprises severing axons in the region of the cornea.

2. The method of claim 1 , wherein treating comprises denervating the inner portion of the cornea.

3. The method of claim 1 , wherein the apparatus comprises an annular ring configured to contact the cornea.

4. The method of claim 1 , wherein the energy comprises radiofrequency energy, heating, cooling, light, or ultrasound.

5. The method of claim 1 , wherein applying energy comprises applying energy to the outer portion according to the denervation treatment profile.

6. The method of claim 1 , wherein denervation comprises severing axons with the nerve sheath intact.

7. The method of claim 1 , wherein the denervation treatment profile comprises an annular denervation treatment profile.

8. The method of claim 1 , wherein the denervation treatment profile corresponds to a depth within the cornea.

9. The method of claim 1 , wherein the denervation treatment profile is localized substantially to the stroma.

10. The method of claim 1 , wherein the denervation treatment profile encompasses nerve bundles.

11. The method of claim 1 , wherein the denervation treatment profile is determined by the intensity of the energy, the duration the energy is applied, or a combination thereof.

12. The method of claim 1 , wherein the denervation treatment profile is localized substantially to the epithelial layer.

13. The method of claim 1 , wherein the treatment profile is configured to denervate nerves at a predetermined depth within the cornea.

14. The method of claim 1 , wherein the treatment profile is configured to denervate nerves of the epithelium without substantial penetration to nerves below a Bowman's membrane of the eye, or to denervate nerves extending along lamella of a stroma disposed between the epithelium and an endothelium of the outer portion.

15. The method of claim 1 , wherein the treatment profile is configured to denervate nerves in the outer portion of the cornea without causing substantial damage to endothelial cells.

16. A method of treating a cornea of an eye, comprising:

applying an apparatus to an anterior surface of a cornea, wherein the cornea comprises an epithelium, a stroma, an inner portion and an outer portion; and

applying energy from the apparatus to denervate a region of the cornea corresponding to a

denervation treatment profile,

wherein denervation comprises stunning corneal nerves, increasing the threshold of the corneal nerves, inhibiting corneal nerve transmission, blocking the corneal nerve transmission, or a combination of any of the foregoing.

17. A method of treating a cornea of an eye, comprising:

applying an apparatus to an anterior surface of a cornea, wherein the cornea comprises an epithelium, a stroma, an inner portion and an outer portion; and

applying energy from the apparatus to denervate a region of the cornea corresponding to a

denervation treatment profile,

wherein denervation comprises denervating nerves without causing substantial damage to the endothelium.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2019
From: REFAELI, OMER
To: NEXIS VISION, INC.
Reel/Frame 051379/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2019
From: NEXIS VISION, INC.
To: NEXIS VISION LIQUIDATING TRUST
Reel/Frame 051379/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2019
From: NEXIS VISION LIQUIDATING TRUST
To: JOURNEY1, INC.
Reel/Frame 051379/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2017
From: ALSTER, YAIR; GIFFORD, HANSON S.; REICH, CARY J.; DE JUAN, EUGENE, JR; SCHOLL, JOHN A.; ALEJANDRO, JOSE D.; SUTTON, DOUGLAS; RAFAELI, OMAR
To: NEXISVISION, INC.
Reel/Frame 043375/0764 →
Continuity (3)
Continuation 13503841
Provisional Application 61279612 · Oct 23, 2009
Related Publication 20180000639A1 · Jan 4, 2018
Cited By (1)
US 12,656,629